The role of chronic self-propagating glial responses in neurodegeneration: Implications for long-lived survivors of human immunodeficiency virus

References

• Barger SW, Smith-Swintosky VL, Rydel RE, Mattson M. β-Amyloid precursor protein mismetabolism and loss of calcium homeostasis in Alzheimer's disease. Ann New York Acad Sci 1993; 695: 158–164
   Google Scholar
• Barnum SR, Jones JL. Differential regulation of C3 gene expression in human astroglioma cells by interferon-gamma and interleukin-1 beta. Neurosci Lett 1995; 197: 121–124
   Google Scholar
• Breteler MM, de Groot RR, van Romunde LK, Hofman A. Risk of dementia in patients with Parkinson's disease, epilepsy, and severe head trauma: a register-based follow-up study. Am J Epidemiol 1995; 142: 1300–1305
   PubMed Web of Science ®Google Scholar
• Buxbaum JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, Gandy SE, Greengard P. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc Natl Acad Sci USA 1992; 89: 10075–10078
   PubMed Web of Science ®Google Scholar
• Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, Masdeu J, Kawas C, Aronson M, Wolfson L. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 1988; 38: 1682–1688
   PubMed Web of Science ®Google Scholar
• Das S, Potter H. Expression of the Alzheimer amyloid-promoting factors α1-antichymotrypsin and apolipoprotein E is induced in astrocytes by IL-1. Neuron 1995; 14: 447–456
   PubMed Web of Science ®Google Scholar
• Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993; 328: 106–113
   PubMed Web of Science ®Google Scholar
• Edwards JK, Larson EB, Hughes JP, Kukull WA. Are there clinical and epidemiological differences between familial and non-familial Alzheimer's disease?. J Amer Geriat Soc 1991; 39: 477–483
   Google Scholar
• Forloni G, Demicheli F, Giorgi S, Bendotti C, Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Mol Brain Res 1992; 16: 128–134
   PubMedGoogle Scholar
• Gautrin D, Gauthier S. Alzheimer's disease: environmental factors and etiologic hypotheses. Can J Neurol Sci 1989; 16: 375–387
   PubMed Web of Science ®Google Scholar
• Gentleman S, Roberts G. Risk factors in Alzheimer's disease. Br Med J 1992; 304: 118–119
   PubMedGoogle Scholar
• Gentleman SM, McKenzie JE, Royston MC, Griffin WST, Graham DI. S100β immunoreactivity in the hippocampus following fatal head injury: effect of survival time. J Neurotoxicol 1997; 17, in press
   Google Scholar
• Giulian D, Woodward J, Young DG, Krebs JF, Lachman LB. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci 1988; 8: 2485–2490
   PubMed Web of Science ®Google Scholar
• Goldgaber D, Harris HW, Hla T, Maciag T, Donnelly RG, Jacobsen JS, Vitek MP, Gajdusek DC. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA 1989; 86: 7606–7610
   PubMed Web of Science ®Google Scholar
• Graham DI, Gentleman SM, Lynch A, Landon M, Roberts GW. Distribution of beta amyloid protein in the brain following severe head injury. Neuropath Appl Neurobiol 1995; 1: 27–34
   Google Scholar
• Graham DI, Gentleman SM, Nicoll JAR, Royston NC, McKenzie JE, Roberts GW, Mrak RE, Griffin WST. Is there a genetic basis for β-amyloid deposition after fatal head injury?. Cell Molec Neurobiol 1997, in press
   Google Scholar
• Graves AB, White E, Koepsell TD, Reifler BV, van Belle G, Larson EB, Raskind M. The association between head trauma and Alzheimer's disease. Amer J Epidemiol 1990; 131: 491–501
   PubMed Web of Science ®Google Scholar
• Griffin WST, Stanley LC, Ling C, White L., MacLeod V, Perrot LJ, White CL, III, Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989; 86: 7611–7615
   PubMed Web of Science ®Google Scholar
• Griffin WST, Sheng JG, Gentleman SM, Graham DI, Mrak RE, Roberts GW. Microglial interleukin-1α expression in human head injur}': correlations with neuronal and neuritic β-amyloid precursor protein expression. Neurosci Lett 1994; 176: 133–136
   PubMed Web of Science ®Google Scholar
• Griffin WST, Sheng JG, Roberts GW, Mrak RE. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J Neuropathol Exp Neurol 1995a; 54: 276–281
   PubMed Web of Science ®Google Scholar
• Griffin WST, Yeralan O, Boop F, Rovnaghi CR, Sheng JR, Mrak RE, Van Eldik LC. Overexpression of the neurotrophic cytokine S100β in human temporal lobe epilepsy. J Neurochem 1995b; 65: 228–233
   PubMedGoogle Scholar
• Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 1988; 23: 138–144
   PubMed Web of Science ®Google Scholar
• Kligman D, Marshak DR. Purification and characterization of a neurite extension factor from bovine brain. Proc Natl Acad Sci USA 1985; 82: 7136–7139
   PubMedGoogle Scholar
• Kure K, Weidenheim KM, Lyman WD, Dickson DW. Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta Neuropathol (Berl) 1990; 80: 393–400
   PubMed Web of Science ®Google Scholar
• Lohler J. Immunopathological reactions in viral infections of the central nervous system. J Neuroimmunol 1988; 20: 181–188
   Google Scholar
• Mackenzie IRA, Miller LA. Senile plaques in temporal lobe epilepsy. Acta Neuropathol 1994; 87: 504–510
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA, Hao C, Monoz DG. Role of microglia in senile plaque formation. Neurobiol Aging 1995; 16: 797–804
   PubMed Web of Science ®Google Scholar
• Manuelidis EE, Manuelidis L. Suggested links between different types of dementias: Creutzfeld-Jakob disease, Alzheimer disease, and retroviral CNS infections. Alzheimer Dis Assoc Discord 1989; 3: 100–109
   Google Scholar
• Marshak DR, Pesce SA, Stanley LC, Griffin WST. Increased S100β neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiol Aging 1992; 13: 1–7
   PubMedGoogle Scholar
• Mayeux R, Ottman R, Tang MX, Noboa-Bauza L, Marder K, Gurland B, Stern Y. Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann Neurol 1993; 33: 494–501
   PubMed Web of Science ®Google Scholar
• McKenzie J, Gentleman SM, Sheng JG, Mann DMA, Mrak RE, Griffin WST, Royston MC. Strocytic S100β deposition in Down's syndrome: relationship with age and β-amyloid. 1997a, Submitted for publication
   Google Scholar
• Mortimer JA, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, Jorm AF, Kokmen E, Kondo K, Rocca WA, et al. Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies, EURODEM Risk Factors Research Group. Int J Epidemiol 1991; 20: S28–35
   PubMed Web of Science ®Google Scholar
• Mrak RE, Sheng JG, Griffin WST. Glial cytokines in Alzheimer's disease: Review and pathogenic implications. Human Pathol 1995; 26: 816–823
   PubMed Web of Science ®Google Scholar
• Mrak RE, Sheng JG, Griffin WST. Correlation of astrocytic S100β expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J Neuropathol Exp Neurol 1996a; 55: 273–279
   PubMed Web of Science ®Google Scholar
• Mrak RE, Sheng JG, Griffin WST. ctivated and phagocytic IL-1α+ microglia, but not primary IL-1α+ microglia, increase with age in normal human brain. Soc Neurosci Abstr 1996b; 22(Part 1)213
   Google Scholar
• Nicoll JAR, Roberts GW, Graham DI. Apolipoprotein E ϵ4 allele is associated with deposition of amyloid β-protein following head injury. Nature Med 1995; 1: 135–137
   PubMed Web of Science ®Google Scholar
• Roberts GW, Gentleman SM, Lynch A, Graham DI. βA-4 amyloid protein deposition in brain after head trauma. Lancet 1991; 338: 1422–1423
   PubMed Web of Science ®Google Scholar
• Roberts GW, Gentleman SM, Lynch A, Murray L, Landon M, Graham DI. β-Amyloid protein disposition in the brain following severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiat 1994; 7: 419–425
   Google Scholar
• Roberts GW, Gentleman SM, Stefan MD, Royston MC. Alzheimer's disease: Prospects for treatment. Lancet 1993; 341: 432
   Google Scholar
• Royston MC, Rothwell NJ, Roberts GW. Alzheimer's disease: Pathology to potential treatments?. Trends Pharmacol Sci 1992; 13: 131–133
   PubMed Web of Science ®Google Scholar
• Sheng JG, Boop FR, Mrak RE, Griffin WST. Increased neuronal β-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1α in microglia. J Neurochem 1994a; 63: 1872–1879
   PubMed Web of Science ®Google Scholar
• Sheng JG, Mrak RE, Griffin WST. S100β protein expression in Alzheimer's disease: potential role in the pathogenesis of neuritic plaques. J Neurosci Res 1994b; 39: 398–404
   PubMedGoogle Scholar
• Sheng JG, Mrak RE, Rovnaghi CR, Kozlowska E, Van Eldik LJ, Griffin WST. Human brain S100β and S100β mRNA expression increases with age: pathogenic implications for Alzheimer's disease. Neurobiol Aging 1996a; 17: 359–363
   PubMed Web of Science ®Google Scholar
• Sheng JG, Ito K, Skinner RD, Mrak RE, Rovnaghi CR, Van Eldik LJ, Griffin WST. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol Aging 1996b; 17: 761–766
   PubMed Web of Science ®Google Scholar
• Sheng JG, Mrak RE, Griffin WST. Microglial interleukin-1α expression in brain regions of Alzheimer's disease: Correlation with neuritic plaque distribution. Neuropathol Appl Neurobiol 1995; 21: 290–301
   PubMed Web of Science ®Google Scholar
• Sheng JG, Mrak RE, Griffin WST. Glial-neuronal interactions in Alzheimer's disease: Progressive association of IL-1α+ microglia and S100β astrocytes with neurofibrillary tangle stages. J Neuropathol Exp Neurol 1997; 56: 285–290
   PubMed Web of Science ®Google Scholar
• Stanley LC, Mrak RE, Woody RC, Perrot LJ, Zhang SX, Marshak DR, Nelson SJ, Griffin WST. Glial cytokines as neuropathogenic factors in HIV infection: Pathogenic similarities to Alzheimer's disease. J Neuropathol Exp Neurol 1994; 53: 231–238
   PubMed Web of Science ®Google Scholar
• van Duijn CM, Tanja TA, Haaxma R, Schulte W, Saan RJ, Lameris AJ, Antonides-Hendriks G, Hofman A. Head trauma and the risk of Alzheimer's disease. Amer J Epidemiol 1992; 135: 775–782
   PubMed Web of Science ®Google Scholar
• Van Eldik LJ, Griffin WST. S100β expression in Alzheimer's disease: Relation to neuropathology in brain regions. Biochem Biophys Acta 1994; 39: 398–404
   Google Scholar
• Williams DB, Annegers JF, Kokmen E, O'Brien PC, Kurland LT. Brain injury and neurologic sequelae: a cohort study of dementia, parkinsonism, and amyotrophic lateral sclerosis. Neurol 1991; 41: 1554–1557
   PubMed Web of Science ®Google Scholar
• Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 1985; 17: 278–282
   PubMed Web of Science ®Google Scholar
• Yankner BA, Duffy LK, Kirschner DA. Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 1990; 250: 279–282
   PubMed Web of Science ®Google Scholar